✦ LIBER ✦

665: Utility of anti-factor Xa levels in pregnant women receiving low molecular weight heparin prophylaxis

✍ Scribed by Allred, Emily; Quinn, Kristen; Thorsen, Julia; Pradarelli, Jason; Baker, Lisa; Szabo, Aniko; Zhao, Shi (Heather); Wassenaar, Timothy; Kuhlman, Randall

Book ID: 119185784
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 78 KB
Volume: 208
Category: Article
ISSN: 1097-6868
DOI: 10.1016/j.ajog.2012.10.831

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monitoring of Anti-Xa in Pregnant Patien

Monitoring of Anti-Xa in Pregnant Patients With Mechanical Prosthetic Valves Receiving Low-Molecular-Weight Heparin: Peak or Trough Levels?

✍ Goland, S.; Schwartzenberg, S.; Fan, J.; Kozak, N.; Khatri, N.; Elkayam, U. 📂 Article 📅 2014 🏛 SAGE Publications 🌐 English ⚖ 253 KB

P14 Correlation between the low molecula

P14 Correlation between the low molecular weight heparin prophylactic dose and the plasma levels of anti Xa activity in pregnant women

✍ G. Mitic; Dj. Jurisic; M. Scekic; D. Spasic; M. Petkovic; B. Jakovljevic; Z.D. J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Author's response: Monitoring Anti-Xa to

Author's response: Monitoring Anti-Xa to prevent thrombosis progression in pregnant women treated with low-molecular weight heparin

✍ Wee-Shian Chan 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Prospective evaluation of bone density i

Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium

✍ Holly L. Casele; Steven A. Laifer 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

Objective: To evaluate changes in bone density in women receiving enoxaparin sodium during pregnancy. Methods: Bone density in the proximal femur was serially measured in 16 women receiving enoxaparin sodium (40 mg daily) during pregnancy. Baseline measurements were taken within 2 weeks of starting

Stability of low molecular weight hepari

Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma

✍ Nicole Birri; Daniela Baumgartner; Tiziana Conte; Anh Huynh; Katja Weller; Marko 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB

Determination of anti-Xa levels in pregn

Determination of anti-Xa levels in pregnant women treated with low molecular weight heparins for prevention of recurrent venous thromboembolism: A case report and review of the literature

✍ Micki Kinori; Nili Saar; Ronit Almog; Dan Justo 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB